Open AccessCost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer
Author(s) -
Haifeng Zheng,
Qian Xie,
Ming Zhan,
Chaohui Jin,
Li Qiu
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s286860
Subject(s) - medicine , helicobacter pylori , cancer , cost effectiveness analysis , population , cost effectiveness , oncology , gastroenterology , environmental health , risk analysis (engineering)
Helicobacter pylori (H. pylori) eradication therapy has been shown to reduce the risk of gastric cancer in patients who have a family history of gastric cancer in first-degree relatives. The aim of this study was to assess the cost-effectiveness of H. pylori eradication therapy in a select population in the People's Republic of China.